Morgan Stanley’s Rain Oncology Inc. Common Stock RAIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-93,054
| Closed | -$112K | – | 8104 |
|
2023
Q4 | $112K | Buy |
93,054
+74,970
| +415% | +$90K | ﹤0.01% | 6122 |
|
2023
Q3 | $15.6K | Sell |
18,084
-39,151
| -68% | -$33.7K | ﹤0.01% | 6562 |
|
2023
Q2 | $68.7K | Buy |
57,235
+32,915
| +135% | +$39.5K | ﹤0.01% | 6093 |
|
2023
Q1 | $213K | Buy |
24,320
+12,033
| +98% | +$105K | ﹤0.01% | 5681 |
|
2022
Q4 | $98.3K | Buy |
12,287
+1,300
| +12% | +$10.4K | ﹤0.01% | 5984 |
|
2022
Q3 | $53K | Sell |
10,987
-7,683
| -41% | -$37.1K | ﹤0.01% | 6387 |
|
2022
Q2 | $105K | Buy |
18,670
+9,953
| +114% | +$56K | ﹤0.01% | 6249 |
|
2022
Q1 | $44K | Buy |
8,717
+3,816
| +78% | +$19.3K | ﹤0.01% | 6771 |
|
2021
Q4 | $63K | Buy |
4,901
+3,439
| +235% | +$44.2K | ﹤0.01% | 6701 |
|
2021
Q3 | $21K | Buy |
1,462
+1,069
| +272% | +$15.4K | ﹤0.01% | 7085 |
|
2021
Q2 | $5K | Buy |
+393
| New | +$5K | ﹤0.01% | 7407 |
|